Last reviewed · How we verify
NCT03582267
The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players
NA trial testing Docosahexaenoic Acid (DHA) in Head Trauma in 50 participants. Completed in 1 August 2019.
1 August 2018
Quick facts
| Lead sponsor | Texas Christian University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 50 |
| Start date | 1 August 2017 |
| Primary completion | 1 August 2018 |
| Estimated completion | 1 August 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Docosahexaenoic Acid (DHA) — full drug profile →
Conditions studied
- Head Trauma — all drugs for Head Trauma →
Sponsor
Texas Christian University
Who can join
Eligibility, any sex, with Head Trauma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Nutrition interventions may present a safe and relatively risk free intervention for protection against subconcussive impacts. Docosahexaenoic acid (DHA, 22:6n-3) is the principal Omega 3 polyunsaturated fatty acid in the brain, playing an integral role in the brain's development and structural integrity. The goal of this study is to determine if supplementation with DHA attenuates blood biomarkers of repetitive head trauma linked to sub-concussive impacts sustained in rugby participation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03582267
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Docosahexaenoic Acid (DHA)
Trials testing the same drug.
- NCT05527106 — Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With Glaucoma · NA · completed
Other recruiting trials for Head Trauma
Currently open trials in the same condition.
- NCT07036146 — Single-center Transversal Observational Study on the Evaluation of S100B Changes in Subjects Attending the Emergency Dep · recruiting
- NCT07195760 — Delayed IntraCranial Hemorrhage in Oral AntiCoagulant Treated Patients With Mild Traumatic Brain Injury · active not recruiting
Other Texas Christian University trials
Trials by the same sponsor.
- NCT07271316 — Alii Supplement Study · Phase 2 · recruiting
- NCT07377331 — Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer · Phase 1 · recruiting
- NCT07180446 — Can Gut Bacteria Predict Who Benefits Most From Exercise? A Gut Supplement to Help Exercise Non-Responders · NA · not yet recruiting
- NCT07105826 — Impact of Prebiotic Sodas on Satiety and Metabolic Responses in Healthy Men · NA · recruiting
- NCT07377318 — Project CARE-D - Online Caregiver Education for Dementia · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03582267 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas Christian University
- Last refreshed: 13 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03582267.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing